![]() |
|
|
|
|||||||
|
|
|
2007-03-09 News Release
Endura Fine Chemicals markets active ingredient for insect repellent Saltigo and the Italian company Endura SpA Fine Chemicals joint venture in the area of insect repellents.
Chemicals group LANXESS is extending its activities in the area of insect
repellents. LANXESS subsidiary Saltigo and the Italian company Endura
SpA Fine Chemicals have signed a contract under whose terms Endura will
market Saltigo’s active ingredient Bayrepel* (Icaridin) with immediate
effect in Central and South America, Africa, the Middle East and India.
"This is another milestone in our drive to market Bayrepel* all over
the globe," said Dr. Axel Westerhaus, Saltigo’s Managing Director. Only recently the active ingredient was also registered in Malaysia.
In addition, Saltigo has also received the approval of the US Environmental
Protection Agency (EPA) for two of its own formulas. The collaboration
with Endura is now going to support product marketing in other important
regions. Saltigo is a technology-based, innovative globally operating company with particular expertise in the custom manufacturing of fine chemicals. Products are exclusively manufactured according to the wishes and needs of the customer. Saltigo employs some 1,400 people at its sites in Leverkusen and Dormagen and achieved sales of approximately EUR about 400 million in 2005. *Bayrepel is a registered trademark of LANXESS.
Click here to view more news headlines.
|
News / Resources - Sovran fungicides controlling plant diseases - Certification, Training and Courses from The American Management Association - Small Quantity Specailist - Plastics, Metals, Tool Steel and ... - Looking for a Study Program? - All this Months News - Changing Jobs? View a Wide Range of Real Estate Nationwide - Golf Equipment Manufacturer -Buy Direct and Save! Copyright - Unless
otherwise stated all
contents of this web site are © 1998/2007 JOBWERX.COM.
– All Rights Reserved. For permission to reproduce any contents of this
web site, please advise our Syndication department: Log onto HELP
|
|
|